H-Phe(4-I)-OHCAS# 24250-85-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 24250-85-9 | SDF | Download SDF |
PubChem ID | 134497 | Appearance | Powder |
Formula | C9H10INO2 | M.Wt | 291.1 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | 4-Iodo-L-phenylalanine; 24250-85-9; 4-Iodophenylalanine; L-4-Iodophenylalanine; P-Iodo-l-phenylalanine | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S)-2-amino-3-(4-iodophenyl)propanoic acid | ||
SMILES | C1=CC(=CC=C1CC(C(=O)O)N)I | ||
Standard InChIKey | PZNQZSRPDOEBMS-QMMMGPOBSA-N | ||
Standard InChI | InChI=1S/C9H10INO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
H-Phe(4-I)-OH Dilution Calculator
H-Phe(4-I)-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.4352 mL | 17.1762 mL | 34.3525 mL | 68.7049 mL | 85.8811 mL |
5 mM | 0.687 mL | 3.4352 mL | 6.8705 mL | 13.741 mL | 17.1762 mL |
10 mM | 0.3435 mL | 1.7176 mL | 3.4352 mL | 6.8705 mL | 8.5881 mL |
50 mM | 0.0687 mL | 0.3435 mL | 0.687 mL | 1.3741 mL | 1.7176 mL |
100 mM | 0.0344 mL | 0.1718 mL | 0.3435 mL | 0.687 mL | 0.8588 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
H-Phe(4-I)-OH
- H-Phe(4-Br)-OH
Catalog No.:BCC3157
CAS No.:24250-84-8
- 2,5-Bis(4-aminophenyl)-1,3,4-oxadiazole
Catalog No.:BCC8501
CAS No.:2425-95-8
- Solifenacin succinate
Catalog No.:BCC4580
CAS No.:242478-38-2
- Thalictrimine
Catalog No.:BCN5097
CAS No.:24240-04-8
- 3-Methyl-9H-carbazol-2-ol
Catalog No.:BCN4666
CAS No.:24224-30-4
- Mianserin
Catalog No.:BCC4134
CAS No.:24219-97-4
- Tabimorelin hemifumarate
Catalog No.:BCC5897
CAS No.:242143-80-2
- Farrerol
Catalog No.:BCN2481
CAS No.:24211-30-1
- 3,3',4,4'-Benzophenone tetracarboxylic dianhydride
Catalog No.:BCC8593
CAS No.:2421-28-5
- Bis(4-hydroxy-3-methylphenyl) sulfide
Catalog No.:BCC8885
CAS No.:24197-34-0
- Epiyangambin
Catalog No.:BCN7029
CAS No.:24192-64-1
- Boc-Glu-OH
Catalog No.:BCC3386
CAS No.:2419-94-5
- 7-Methoxy-8-Hydroxy-4-Phenylcoumarin
Catalog No.:BCC8292
CAS No.:24258-36-4
- Shikokianin
Catalog No.:BCN3278
CAS No.:24267-69-4
- Furanodienone
Catalog No.:BCN3010
CAS No.:24268-41-5
- Cannabidivarin
Catalog No.:BCN7536
CAS No.:24274-48-4
- Acetylcephalotaxine
Catalog No.:BCN5098
CAS No.:24274-60-0
- Sodium ferulic
Catalog No.:BCN8542
CAS No.:24276-84-4
- Boc-Glu-OtBu
Catalog No.:BCC3388
CAS No.:24277-39-2
- Mycophenolic acid
Catalog No.:BCC4803
CAS No.:24280-93-1
- Hesperidin methylchalcone
Catalog No.:BCN8125
CAS No.:24292-52-2
- Scandine
Catalog No.:BCN5099
CAS No.:24314-59-8
- Cephalotaxine
Catalog No.:BCN2957
CAS No.:24316-19-6
- 9-Fluorenylmethanol
Catalog No.:BCC2801
CAS No.:24324-17-2
Further analogues of plant peptide hormone phytosulfokine-alpha (PSK-alpha) and their biological evaluation.[Pubmed:15736141]
J Pept Sci. 2005 Sep;11(9):589-92.
Phytosulfokine-alpha (PSK-alpha), a sulfated growth factor of structure H-Tyr(SO3H)-Ile-Tyr(SO3H)-Thr-Gln-OH universally found in both monocotyledons and dicotyledons, strongly promotes proliferation of plant cells in culture. In studies on the structure/activity relationship of PSK-alpha the synthesis was performed of a series of a further 23 analogues modified in position 1, 3 or 4 as well as simultaneously in positions 1 and 3 of the peptide chain. Peptides were synthesized by the solid phase method according to the Fmoc procedure on a Wang-resin. Free peptides were released from the resin by 95% TFA in the presence of EDT. All peptides were tested by competitive binding assay to the carrot membrane using 3H-labelled PSK-alpha according to the test of Matsubayashi et al. Among these peptide analogues, [H-Phe(4-Cl)1]-PSK-alpha (IV), [H-Phe(4-I)1]-PSK-alpha (VII), and [Phe(4-Cl)3]-PSK-alpha (XI) retained 30% PSK-alpha activity. Analogue [Tyr(PO3H2)3]-PSK-alpha (IX) showed 10% of PSK-alpha activity.